Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

Stephane Heymans, Emilio Hirsch, Stefan D. Anker, Pal Aukrust, Jean Luc Balligand, Jan W. Cohen-Tervaert, Helmut Drexler, Gerasimos Filippatos, Stephan B. Felix, Lars Gullestad, Denise Hilfiker-Kleiner, Stefan Janssens, Roberto Latini, Gitte Neubauer, Walter J. Paulus, Burkert Pieske, Piotr Ponikowski, Blanche Schroen, Heinz Peter Schultheiss, Carsten TschöpeMarc Van Bilsen, Faiez Zannad, John McMurray, Ajay M. Shah

Research output: Contribution to journalArticle

Abstract

The increasing prevalence of heart failure poses enormous challenges for health care systems worldwide. Despite effective medical interventions that target neurohumoral activation, mortality and morbidity remain substantial. Evidence for inflammatory activation as an important pathway in disease progression in chronic heart failure has emerged in the last two decades. However, clinical trials of 'anti-inflammatory' therapies (such as anti-tumor necrosis factor-α approaches) have to date failed to show benefit in heart failure patients. The Heart Failure Association of the European Society of Cardiology recently organized an expert workshop to address the issue of inflammation in heart failure from a basic science, translational and clinical perspective, and to assess whether specific inflammatory pathways may yet serve as novel therapeutic targets for this condition. This consensus document represents the outcome of the workshop and defines key research questions that still need to be addressed as well as considering the requirements for future clinical trials in this area.

Original languageEnglish
Pages (from-to)119-129
Number of pages11
JournalEuropean Journal of Heart Failure
Volume11
Issue number2
DOIs
Publication statusPublished - Feb 2009

Keywords

  • Heart failure
  • Inflammation
  • Treatment

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology'. Together they form a unique fingerprint.

  • Cite this

    Heymans, S., Hirsch, E., Anker, S. D., Aukrust, P., Balligand, J. L., Cohen-Tervaert, J. W., Drexler, H., Filippatos, G., Felix, S. B., Gullestad, L., Hilfiker-Kleiner, D., Janssens, S., Latini, R., Neubauer, G., Paulus, W. J., Pieske, B., Ponikowski, P., Schroen, B., Schultheiss, H. P., ... Shah, A. M. (2009). Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 11(2), 119-129. https://doi.org/10.1093/eurjhf/hfn043